Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research.

Maturitas
J M PavonM S Okun

Abstract

The incidence and prevalence of Parkinson's disease (PD) is expected to rise precipitously over the next several decades, as will the associated healthcare related costs. The epidemiology and disease manifestations of PD may differ when comparing women to men. Women are for example less likely to acquire PD, and in several studies have demonstrated a delayed onset of motor symptoms. Women, however, are more likely to experience PD-related complications that may lead to disability (e.g. depression and medication-associated dyskinesia). Further, there are purported differences in the treatment and treatment outcomes in PD men compared to women. Whether estrogen, other hormonal activity, or whether multiple factors underpin these findings remains unknown. Also unknown is whether estrogen itself may represent a therapeutic option for symptomatic PD treatment. This review summarizes what is known about gender differences in epidemiology, clinical features, treatment outcomes (medical and surgical/deep brain stimulation), and social impact among all available PD studies. We offer expert opinion regarding the shortcomings of the current evidence, and we propose a detailed list of studies that will help to clarify important gender rela...Continue Reading

References

Feb 1, 1978·Annals of Neurology·J W Langston, L S Forno
Jun 1, 1992·American Journal of Public Health·M Kelly-HayesP M Odell
Jul 1, 1993·Neuroendocrinology·M Morissette, T Di Paolo
May 5, 1999·Neurology·R Saunders-PullmanS Bressman
May 19, 2000·Parkinsonism & Related Disorders·G Hariz, M I Hariz
Aug 10, 2000·Journal of Cognitive Neuroscience·J S JanowskyE Orwoll
Aug 17, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·A SchragN Quinn
Jul 11, 2001·Neurobiology of Aging·A RuitenbergM M Breteler
Sep 18, 2002·Mayo Clinic Proceedings·Sotirios A ParashosWalter A Rocca
Dec 5, 2002·Journal of Epidemiology·Seiji MoriokaTsutomu Hashimoto
Mar 18, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·G F WootenJ Patrie
Jun 24, 2004·Archives of Neurology·Lillian J CurrieG Frederick Wooten
Feb 25, 2005·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·C ScaglioneUNKNOWN Bologna, Genova, Parma and Pisa Universities group for the study of REM Sleep Behavior Disorder in Parkinson's Disease
Jul 11, 2007·Neurology·Kevin M BiglanUNKNOWN Parkinson Study Group CALM-PD Investigators
Feb 20, 2008·Aging Clinical and Experimental Research·Ricardo O GuerraMaria Victoria Zunzunegui
Feb 19, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Anja Diem-ZangerlWerner Poewe
Sep 10, 2009·The Open Nursing Journal·Mary Kalfoss, Liv Halvorsrud
Nov 4, 2009·Neurology·E Y UcUNKNOWN Parkinson Study Group DATATOP Investigators

❮ Previous
Next ❯

Citations

Sep 21, 2013·The Nurse Practitioner·Ju Young Shin, Cristina C Hendrix
Sep 16, 2011·Journal of the Neurological Sciences·T LitwinA Członkowska
Jun 15, 2011·Gender Medicine·Rachel Saunders-PullmanSusan B Bressman
Oct 15, 2011·The International Journal of Neuroscience·Ebba LohmannMurat Emre
Mar 3, 2015·Geriatric Nursing·Ju Young ShinIngrid Pretzer-Aboff
Nov 5, 2013·Parkinsonism & Related Disorders·Chava PeretzNir Giladi
Apr 29, 2014·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Michal LubomskiDavid R Williams
Jun 18, 2016·Neuroscience Journal·Emanuela ZagniDelia Colombo
May 26, 2016·The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses·Ju Young Shin, Barbara Habermann
Nov 5, 2016·BMC Complementary and Alternative Medicine·Sook-Hyun LeeSabina Lim
Nov 16, 2016·Journal of Gerontological Nursing·Ju Young ShinBarbara Habermann
Sep 25, 2016·Western Journal of Nursing Research·Ju Young ShinBarbara Habermann
Aug 30, 2017·Neuro-degenerative Diseases·Jee-Eun YoonJin Whan Cho
Jul 31, 2014·The Journal of Pharmacology and Experimental Therapeutics·Simone M R CamargoFrançois Verrey
Jun 5, 2018·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·JuHee LeeYoungho Sohn
Nov 7, 2019·Acta Neurologica Scandinavica·Maria SperensGun-Marie Hariz
Jul 4, 2017·Acta Neurologica Scandinavica·D GeorgievG-M Hariz
Sep 28, 2020·Brain : a Journal of Neurology·Christina TremblayAlain Dagher
Oct 20, 2020·Frontiers in Neurology·Irene GöttgensSabine Oertelt-Prigione

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Neurology, Neurosurgery, and Psychiatry
Charlotte A HaaxmaMartin W I M Horstink
Movement Disorders : Official Journal of the Movement Disorder Society
Ivy N Miller, Alice Cronin-Golomb
Journal of Neurology, Neurosurgery, and Psychiatry
David J Burn
Journal of Neurology
Yasuhiko BabaRyan J Uitti
© 2021 Meta ULC. All rights reserved